Givaudan | GIVN - Le Bénéfice D'Exploitation

Prix De L'Action
2,653.00
Variation Quotidienne
7.00 0.26%
Mensuellement
-13.39%
Annuel
-30.79%
Q1 Prévisions
2,593.94




Le Bénéfice D'Exploitation Changement Date
Air Liquide EUR 2.84B 6.65B 2025-12
Akzo Nobel EUR 217M 80M 2025-12
Anheuser-Busch USD 4.2B 192M 2025-09
Arkema EUR 25M 82M 2025-12
Associated British Foods GBP 825M 60M 2025-12
BASF EUR -175M 668M 2025-12
Bayer EUR 1.11B 1.65B 2025-12
Beiersdorf EUR 504M 312M 2025-12
British American Tobacco GBP 5B 86M 2025-12
Covestro EUR -324M 5.72B 2025-12
Croda International GBP 113M 53.55M 2024-12
Danone EUR 1.81B 249M 2025-06
Diageo GBP 3.26B 1.92B 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 663M 213.06M 2025-12
Givaudan CHF 610M 149M 2025-12
Heineken EUR 1.97B 40M 2025-12
Henkel EUR 1.42B 187M 2025-12
International Flavors Fragrances USD 113M 129M 2025-12
Johnson Matthey GBP 142M 89M 2025-12
Kerry EUR 463.5M 94.2M 2024-12
Lonza CHF 673M 243M 2025-06
L'Oréal EUR 3.92B 824.8M 2025-12
Merck EUR 474M 738M 2025-12
Nestle CHF 6.84B 293M 2025-12
Pernod Ricard EUR 967M 930M 2025-06
Reckitt Benckiser GBP 747M 92M 2024-12
SGS CHF 253M 45.5M 2024-12
Sika AG CHF 724.9M 73.2M 2025-12
Solvay EUR 60M 78M 2025-12
Tate & Lyle GBP 129M 0 2025-12
Umicore EUR 304.3M 959.85M 2025-06
Victrex GBP 22.9M 1.1M 2025-12